Viewing Study NCT00537095


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-01-22 @ 9:44 AM
Study NCT ID: NCT00537095
Status: COMPLETED
Last Update Posted: 2024-04-19
First Post: 2007-09-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
Sponsor: Genzyme, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thyroid Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None follicular View
None papillary View